{"schema_version":"1","generated_at":"2026-11-11T07:41:13.176Z","data_as_of":null,"url":"https://www.findmykol.com/kol/jacob-lalezari","json_url":"https://www.findmykol.com/kol/jacob-lalezari/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"jacob-lalezari","name":"Jacob Lalezari","credential":"MD","specialty":"Internal Medicine","specialty_raw":"Internal Medicine","therapeutic_area":"Primary Care","therapeutic_areas":["Primary Care"],"institution":"Quest Clinical Research","institution_url":"https://www.findmykol.com/institution/quest-clinical-research","city":"San Francisco","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1124173554","orcid":"0000-0002-2744-4918","openalex":"A5002916327"},"summary":"Jacob Lalezari is a Primary Care physician affiliated with Quest Clinical Research. OpenAlex indexes 211 publications with 15,609 citations (h-index 62); ClinicalTrials.gov lists 11 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Internal Medicine profiles in the FindMyKOL directory.","overview":null,"focus":{"indications":[],"research_topics":["Primary Care"]},"scholarship":{"works_count":211,"cited_by_count":15609,"h_index":62,"latest_activity_year":2025,"citation_standing":{"top_percent":5,"cohort":"Internal Medicine","method":"https://www.findmykol.com/about#citation-standing"},"source":"works"},"trials":{"count":11,"shown":3,"withheld":8,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT05271370","title":"An Extension Protocol for Virologically Suppressed Subjects Who Successfully Completed PRO140_CD03 Study","phase":"PHASE2/PHASE3","status":"TERMINATED","role":"Overall official","sponsor":"CytoDyn, Inc.","source_url":"https://clinicaltrials.gov/study/NCT05271370","trial_url":"https://www.findmykol.com/trial/NCT05271370"},{"nct":"NCT04504942","title":"Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"CytoDyn, Inc.","source_url":"https://clinicaltrials.gov/study/NCT04504942","trial_url":"https://www.findmykol.com/trial/NCT04504942"},{"nct":"NCT04347239","title":"Evaluate the Efficacy & Safety of Leronlimab in Patients With Severe or Critical COVID-19","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"CytoDyn, Inc.","source_url":"https://clinicaltrials.gov/study/NCT04347239","trial_url":"https://www.findmykol.com/trial/NCT04347239"}],"source":"trials"},"payments":{"company_count":5,"program_years":{"first":2021,"last":null},"rows_total":32,"shown":3,"withheld":29,"rows":[{"payer":"AbbVie","program_year":2025,"amount_usd":174013.78,"payment_count":17,"source_url":"https://openpaymentsdata.cms.gov/search?query=1124173554"},{"payer":"CSL Behring","program_year":2025,"amount_usd":8830.25,"payment_count":7,"source_url":"https://openpaymentsdata.cms.gov/search?query=1124173554"},{"payer":"Merck & Co.","program_year":2025,"amount_usd":2168.24,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1124173554"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1124173554","source":"payments"},"similar":[{"name":"Fei Wang","slug":"fei-wang","institution":"Cornell University","specialty":"Family Medicine","url":"https://www.findmykol.com/kol/fei-wang","json_url":"https://www.findmykol.com/kol/fei-wang/profile.json"},{"name":"Michael Hassman","slug":"michael-hassman","specialty":"Adult Medicine","url":"https://www.findmykol.com/kol/michael-hassman","json_url":"https://www.findmykol.com/kol/michael-hassman/profile.json"},{"name":"Barbara Rizzardi","slug":"barbara-rizzardi","specialty":"Internal Medicine","url":"https://www.findmykol.com/kol/barbara-rizzardi","json_url":"https://www.findmykol.com/kol/barbara-rizzardi/profile.json"},{"name":"Kimball Johnson","slug":"kimball-johnson","specialty":"Internal Medicine","url":"https://www.findmykol.com/kol/kimball-johnson","json_url":"https://www.findmykol.com/kol/kimball-johnson/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":8,"payments":29}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}